Conversion to Mycophenolate Mofetil Monotherapy in Liver Recipients: Calcineurin Inhibitor Levels are Key

Conversion to Mycophenolate Mofetil Monotherapy in Liver Recipients: Calcineurin Inhibitor Levels are Key

The use of calcineurin inhibitors (CNI) after liver transplantation is associated with post-transplant nephrotoxicity. Conversion to myc-ophenolate mofetil (MMF) monotherapy improves renal function, but is related to graft rejection in some recipients. Our aim was to identify variables associated wi...

Full description

Bibliographic Details
Main Authors: Blanca Norero, Carolina A. Serrano, Alberto Sanchez-Fueyo, Ignacio Duarte, Javiera Torres, Mauricio Ocquetau, Francisco Barrera, Marco Arrese, Alejandro Soza, Carlos Benítez
Format: Article
Language:English
Published: Elsevier 2017-01-01
Series:Annals of Hepatology
Subjects:
Calcineurin inhibitors
Minimization
Mycophenolate mofetil
Conversion
Liver transplantation
Renal function
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119303667

Internet

http://www.sciencedirect.com/science/article/pii/S1665268119303667

Similar Items